Related Experiment Videos
B cell differentiation factor-induced B cell maturation: regulation via reduction in cAMP
1Division of Clinical Immunology, Mount Sinai Medical Center, New York, New York 10029, USA.
Cellular Immunology
|April 15, 1995
Summary
A novel B cell differentiation factor (BCDF) reduces intracellular cyclic AMP (cAMP) levels, a critical step for B cell maturation. This pathway, involving Gi-linked receptors, is crucial for B cell differentiation and Ig secretion.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Human B cell differentiation pathways are poorly understood.
- A novel B cell differentiation factor (BCDF), 446-BCDF, has been identified.
Purpose of the Study:
- To investigate the intracellular signaling mechanisms of 446-BCDF.
- To determine the role of second messenger systems in 446-BCDF-induced B cell differentiation.
Main Methods:
- B cells were exposed to 446-BCDF and intracellular cAMP levels were measured.
- The effects of cAMP modulators (analog, stimulator, inhibitors) on B cell differentiation were assessed.
- Pertussis toxin (PTX), a Gi protein inhibitor, was used to elucidate the signaling pathway.
Main Results:
- 446-BCDF significantly decreased intracellular cAMP levels in B cells.
- Inhibition of the cAMP decrease blocked 446-BCDF-induced B cell differentiation.
- Pertussis toxin blocked 446-BCDF-induced differentiation, suggesting Gi-protein involvement.
- Other B cell differentiation cytokines (IL2, IL6) also reduced cAMP levels.
Conclusions:
- The reduction of intracellular cAMP is a critical event in 446-BCDF-induced B cell differentiation.
- 446-BCDF likely signals through a Gi-linked receptor, inhibiting adenylate cyclase and reducing cAMP.
- This cAMP reduction pathway may be a general mechanism for terminal B cell maturation and Ig secretion.